Back
Sage Therapeutics Stock Price Chart
Sponsored
SAGE
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
SAGE
Sage Therapeutics
Last Price:
7.91
Seasonality Move:
14.13%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- The current trend is relatively stagnant and SAGE is experiencing slight buying pressure.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.58 | Buy |
20-day SMA: | 7.83 | Buy |
50-day SMA: | 9.17 | Sell |
200-day SMA: | 15.76 | Sell |
8-day EMA: | 7.67 | Buy |
20-day EMA: | 7.9 | Buy |
50-day EMA: | 8.93 | Sell |
200-day EMA: | 15.13 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 46.7 | Sell |
Chaikin Money Flow: | 113452 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.55 - 8.35) | Sell |
Bollinger Bands (100): | (8.54 - 12.24) | Sell |
Sage Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 7.91 while SAGE 8-day simple moving average is 7.58, which is a Buy signal.
- The stock price of SAGE is 7.91 while Sage Therapeutics 20-day SMA is 7.83, which makes it a Buy.
- Sage Therapeutics 50-day simple moving average is 9.17 while SAGE share price is 7.91, making it a Sell technically.
- SAGE stock price is 7.91 and Sage Therapeutics 200-day simple moving average is 15.76, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
27
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a Sell
The current Sage Therapeutics [SAGE] share price is $7.91. The Score for SAGE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
482.91M
Price in USD:
7.91
Share Volume:
368.2K
Sage Therapeutics 52-Week Range
52-Week High:
28.26
52-Week Low:
7.19
Sell
27
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?
The Sage Therapeutics stock price is 7.91 USD today. -
Will SAGE stock go up or go down?
Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sage Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
- Sage Therapeutics share price is 7.91 while SAGE 8-day exponential moving average is 7.67, which is a Buy signal.
- The stock price of SAGE is 7.91 while Sage Therapeutics 20-day EMA is 7.90, which makes it a Buy.
- Sage Therapeutics 50-day exponential moving average is 8.93 while SAGE share price is 7.91, making it a Sell technically.
- SAGE stock price is 7.91 and Sage Therapeutics 200-day simple moving average is 15.13, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.13 per share, an increase next quarter of $0.23 per share, an increase this year of $2.99 per share, and an increase next year of $1.38 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
- SAGE Moving Average Covergence Divergence (MACD) indicator is -0.37, suggesting Sage Therapeutics is a Sell
- Sage Therapeutics Relative Strength Index (RSI) is 46.7, which suggest Sage Therapeutics is oversold
- The Bollinger Bands (25) for Sage Therapeutics is (7.55 - 8.35), which suggest Sage Therapeutics is a Sell
- The Bollinger Bands (100) for Sage Therapeutics is (8.54 - 12.24), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.